SC Mandates 'No-Fault' Compensation for Covid Vaccine Side Effects

This policy is highly significant because it shifts the burden of proof from the affected individual to the State. Previously, individuals had to prove negligence in civil courts, which is a lengthy and difficult process. The "no-fault" mechanism acknowledges the State's constitutional obligation to public health during a mass vaccination drive, ensuring that citizens who suffer adverse effects are compensated without having to demonstrate fault. This provides a crucial safety net and upholds the Right to Health.

The core difference lies in the requirement to prove negligence.

• •No-Fault Compensation: Under this system, individuals or their families do not need to prove that the government or vaccine manufacturer was negligent. Compensation is provided simply because a serious adverse event or death occurred following vaccination, acknowledging the state's responsibility in a public health drive.
• •Traditional Legal Recourse: This typically involves filing a civil lawsuit where the plaintiff (affected party) must prove that the defendant (government/manufacturer) acted negligently, leading to the injury or death. This process is often complex, time-consuming, and expensive, requiring extensive evidence and legal expertise.

The Supreme Court explicitly linked its directive to the 'Right to Health', which is an integral part of the 'Right to Life' guaranteed by Article 21 of the Indian Constitution.

• •Constitutional Linkage: The Court asserted that the State's constitutional obligation to protect public health extends beyond just providing healthcare to also ensuring a structured compensation mechanism for those harmed during a state-led vaccination drive. This reinforces the idea that the State has a positive duty to safeguard citizens' welfare and dignity.
• •Crucial Significance: This linkage is crucial because it elevates vaccine injury compensation from a mere policy matter to a fundamental constitutional right. It means the State cannot simply deny responsibility but is constitutionally bound to provide remedies, strengthening citizen protection in public health interventions.

The most relevant Articles are Article 21 (Right to Life, encompassing Right to Health) and Article 38 (State's duty to secure a social order for the promotion of welfare of the people).

• •Article 21: This is paramount, as the judgment grounds the 'Right to Health' and bodily integrity within it, making compensation a constitutional obligation.
• •Article 38: This DPSP reinforces the state's duty to promote the welfare of the people by securing a social order, which includes providing remedies for those harmed by state-led initiatives.
• •Common Trap: Examiners might try to link it to other DPSPs like Article 47 (duty to raise the level of nutrition and the standard of living and to improve public health) or fundamental duties, but the core constitutional obligation for compensation stems directly from Article 21 and is supported by Article 38. Focus on the explicit mentions in the judgment data.

For Mains, it's crucial to interpret the data with nuance, acknowledging both the scale of the vaccination drive and the significance of reported adverse events.

• •Scale vs. Incidence: While 1.5 billion doses were administered, indicating a massive public health effort, the 50,000+ deaths and injuries reported by petitioners (and 1,200 AEFI reported to Centre) highlight that even a small percentage of severe adverse events can impact a significant number of individuals.
• •Inadequacy of Existing Mechanisms: The Court's observation that existing AEFI reporting was inadequate for compensation suggests a gap between monitoring adverse events and providing redressal. The data, therefore, underscores the need for a robust compensation policy, not just a reporting system.
• •State's Obligation: The judgment emphasizes that irrespective of the low incidence rate, the State has a constitutional obligation to protect public health and provide remedies for those who suffered grave outcomes during a state-led drive, especially when existing mechanisms failed to offer adequate recourse.

The Centre could face several significant challenges in formulating and implementing this policy.

• •Defining "No-Fault" Criteria: Establishing clear, objective criteria to determine a causal link between vaccination and adverse events without requiring proof of negligence will be complex. This includes defining "serious adverse effects" and the acceptable timeframe for their manifestation.
• •Funding Mechanism: Securing adequate and sustainable funding for compensation, especially given the potential for a large number of claims (over 50,000 deaths and injuries were reported by petitioners), will be a major financial undertaking.
• •Administrative Burden: Setting up a robust, transparent, and efficient administrative machinery to process claims, verify medical records, and disburse compensation promptly will require significant resources and expertise.
• •Preventing Misuse: Designing a system that is accessible to genuine claimants while also preventing fraudulent claims will be a delicate balance.
• •Public Trust and Perception: The policy's success will also depend on building public trust that the system is fair and effective, especially after initial skepticism regarding vaccine side effects.

This ruling is a significant example of judicial activism, particularly in the realm of public health and fundamental rights.

• •Expanding Article 21: The Supreme Court has consistently expanded the scope of Article 21 (Right to Life) to include various ancillary rights, and this judgment further solidifies the 'Right to Health' by mandating a state-led compensation mechanism for vaccine injuries.
• •Checks and Balances: It demonstrates the judiciary's role in ensuring accountability of the executive, especially when state actions (like a mass vaccination drive) have widespread public impact. The Court stepped in where existing executive mechanisms were deemed inadequate.
• •Proactive Role: Rather than waiting for legislative action, the Court has proactively directed the Centre to formulate a policy, underscoring its role as a protector of fundamental rights and a driver of social change in critical areas like public health.

The Supreme Court deemed existing AEFI mechanisms inadequate primarily because their focus was on surveillance and monitoring of adverse events, not on providing a structured compensation or redressal for individuals who suffered harm.

• •Reporting vs. Redressal: AEFI systems are primarily designed for epidemiological tracking, to identify potential safety signals and inform public health policy, not to facilitate individual claims for financial relief.
• •Burden of Proof: Even if an AEFI was reported, it did not automatically lead to compensation. Affected families still faced the daunting task of proving negligence or a direct causal link in civil courts, which the AEFI system was not equipped to address.
• •Lack of Uniform Policy: The absence of a clear, uniform, and accessible compensation policy meant that families were left without a specific legal framework to seek relief, forcing them into complex and often futile litigation.

A state-led mass vaccination drive with a 'no-fault' compensation policy carries significant ethical implications, balancing public good with individual rights.

• •State's Moral Obligation: It reinforces the ethical principle that when the State encourages or mandates a public health intervention for the collective good, it assumes a moral and constitutional obligation to protect individuals who suffer unforeseen harm, even if the intervention is generally safe.
• •Balancing Public Health and Individual Autonomy: While mass vaccination is crucial for public health, a compensation policy acknowledges that individuals bear a personal risk for the collective benefit. This ethically balances the utilitarian goal of herd immunity with the deontological duty to protect individual well-being.
• •Trust and Transparency: Implementing such a policy can enhance public trust in future public health campaigns by demonstrating the government's commitment to accountability and care for its citizens, even in adverse circumstances. It promotes transparency about potential risks.
• •Resource Allocation: Ethically, it raises questions about equitable resource allocation – how much should be spent on compensation versus other public health priorities, and how to ensure fairness in distribution.

Aspirants should closely monitor the Centre's actions following the Supreme Court's directive.

• •Policy Formulation: The immediate next step will be the Centre's drafting of the actual "no-fault" compensation policy. Details regarding eligibility, compensation amounts, application process, and dispute resolution will be crucial.
• •Legislative/Executive Action: Observe whether this policy is implemented through executive orders or if it necessitates new legislation, which could indicate its long-term institutionalization.
• •Impact on Future Campaigns: This judgment sets a precedent. Future large-scale public health drives (e.g., for new pandemics or diseases) will likely need to incorporate similar compensation mechanisms from the outset, potentially increasing planning complexity and costs but also enhancing public confidence.
• •Judicial Scrutiny: Any policy formulated by the Centre will likely be subject to further judicial scrutiny to ensure it aligns with the spirit and letter of the Supreme Court's directive.